Buprenorphine Therapy for Opioid Use Disorder

Area of Science:

• Addiction research
• Pharmacology
• Public health

Background:

• Opioid misuse has reached epidemic levels in the US, leading to increased opioid use disorder, overdoses, and deaths.
• Addiction is a chronic brain disease influenced by genetics, affecting motivation, inhibition, and cognition.
• Successful buprenorphine treatment requires stable comorbidities and a safe, substance-free environment.

Purpose of the Study:

• To review the efficacy and safety of buprenorphine in treating opioid use disorder.
• To outline the role of family physicians in prescribing buprenorphine.
• To discuss patient management strategies during medication-assisted treatment.

Main Methods:

• Review of buprenorphine as a partial opioid agonist.
• Comparison of buprenorphine with methadone and placebo.
• Discussion of patient characteristics and treatment monitoring.

Main Results:

• Buprenorphine is as effective as methadone for treatment retention and reduced opioid use at dosages of 7 mg/day.
• Dosages of 16 mg/day are superior to placebo.
• Buprenorphine has a safety ceiling effect, limiting respiratory depression in overdose.

Conclusions:

• Buprenorphine is a well-tolerated and effective medication-assisted treatment for opioid use disorder.
• Family physicians can prescribe buprenorphine after obtaining a waiver.
• Ongoing monitoring and behavioral therapy are crucial for successful treatment outcomes.